The Genome Technology Access Center at the McDonnell Genome Institute (GTAC@MGI) at Washington University School of Medicine in St. Louis is teaming up with PercayAI, a recently-launched augmented intelligence software company, to create technology that can accelerate drug development, The technology, CompBio, mimics the thought processes of scientists, rapidly identifying non-obvious relationships within complex, -omic and multi-omic biological data sets.

“Scaling tasks well beyond that of normal human limitations, the power and potential of this Augmented Intelligence system arises from pairing humans and machines, so that the human – a drug researcher in this case – is learning from the machine and, at the same time, the machine is learning from the human,” Richard Head, Associate Professor of Genetics and Director of GTAC at Washington University School of Medicine said in a statement. “We’re leveraging this in CompBio to allow researchers to explore the biological landscape and rapidly uncover insights at every stage of the drug R&D process.”